Bionomics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	0.02	0.02	0.26	0	0.05
Revenue Growth (YoY)	-	-91.64%	-	-	-
Gross Profit	0.02	0.02	0.26	0	0.05
Selling, General & Admin	-0.88	13.01	11.4	7.26	6.29
Research & Development	1.12	19.61	16	5.76	5.83
Operating Expenses	0.25	32.62	27.4	13.02	12.12
Operating Income	-0.22	-32.6	-27.13	-13.02	-12.07
Interest Expense / Income	0.03	0.03	0.04	1.44	1.85
Other Expense / Income	30.75	-0.58	-5.23	-5.58	-6.59
Pretax Income	-31	-32.05	-21.95	-8.88	-7.33
Income Tax	0	-0.21	-0.19	-0.19	-0.21
Net Income	-31.01	-31.85	-21.76	-8.7	-7.12
Shares Outstanding (Basic)	1,487	1,469	1,310	1,299	-
Shares Change	14.43%	12.16%	0.80%	-	-
EPS (Basic)	50.04	-3.96	-3.96	-1.98	-1.98
EPS (Diluted)	50.04	-3.96	-3.96	-1.98	-1.98
Free Cash Flow	-26.64	-21.34	-21.58	-7.5	-3.65
Free Cash Flow Per Share	-3.23	-2.62	-2.97	-1.04	-
Gross Margin	100.00%	100.00%	100.00%	-	100.00%
Operating Margin	-1020.40%	-147875.51%	-10292.00%	-	-25864.20%
Profit Margin	-140642.49%	-144450.30%	-8253.62%	-	-15255.00%
Free Cash Flow Margin	-120838.18%	-96808.49%	-8186.33%	-	-7814.77%
EBITDA	-	-32.02	-21.91	-7.44	-5.48
EBITDA Margin	-	-145255.68%	-8309.63%	-	-11742.82%
EBIT	-30.97	-32.02	-21.91	-7.44	-5.48
EBIT Margin	-140481.95%	-145255.68%	-8309.63%	-	-11742.82%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).